These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30755792)

  • 1. Recent advances in the clinical management of autosomal dominant polycystic kidney disease.
    Torra R
    F1000Res; 2019; 8():. PubMed ID: 30755792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant policystic kidney disease, more than a renal disease.
    Torra R
    Minerva Endocrinol; 2014 Jun; 39(2):79-87. PubMed ID: 24736482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two cases of autosomal dominant polycystic kidney disease treated with hemodialysis associated with polycystic liver complications related to the cause of death].
    Saima S; Suzuki Y; Yoshimoto K; Nakamura Y; Munakata A
    Nihon Jinzo Gakkai Shi; 1996 Jun; 38(6):278-84. PubMed ID: 8752971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic and renal manifestations in autosomal dominant polycystic kidney disease: a dichotomy of two ends of a spectrum.
    van Gulick JJ; Gevers TJ; van Keimpema L; Drenth JP
    Neth J Med; 2011 Sep; 69(9):367-71. PubMed ID: 21978978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic kidney disease: etiology, pathogenesis, and treatment.
    Martinez JR; Grantham JJ
    Dis Mon; 1995 Nov; 41(11):693-765. PubMed ID: 7587886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical Manifestations in Autosomal Dominant Polycystic Kidney Disease (ADPKD)].
    Piscopo G; Capolongo G
    G Ital Nefrol; 2016; 33(5):. PubMed ID: 27796023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant polycystic kidney disease: pathophysiology and treatment.
    McCarthy S; McMullen M
    ANNA J; 1997 Feb; 24(1):45-51; quiz 52-3. PubMed ID: 9146123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical problems in hemodialysis patients with autosomal dominant polycystic kidney disease.
    Kocyigit I; Eroglu E; Gungor O
    Semin Dial; 2018 May; 31(3):268-277. PubMed ID: 29664556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of cysts infection in ADPKD].
    Kurashige M; Hanaoka K; Hosoya T
    Nihon Jinzo Gakkai Shi; 2012; 54(4):517-21. PubMed ID: 24236343
    [No Abstract]   [Full Text] [Related]  

  • 10. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Chapman AB; Devuyst O; Eckardt KU; Gansevoort RT; Harris T; Horie S; Kasiske BL; Odland D; Pei Y; Perrone RD; Pirson Y; Schrier RW; Torra R; Torres VE; Watnick T; Wheeler DC;
    Kidney Int; 2015 Jul; 88(1):17-27. PubMed ID: 25786098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of autosomal dominant polycystic kidney disease in children and adolescents.
    Reddy BV; Chapman AB
    Pediatr Nephrol; 2017 Jan; 32(1):31-42. PubMed ID: 27034070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney enlargement and multiple liver cyst formation implicate mutations in PKD1/2 in adult sporadic polycystic kidney disease.
    Fujimaru T; Mori T; Sekine A; Mandai S; Chiga M; Kikuchi H; Ando F; Mori Y; Nomura N; Iimori S; Naito S; Okado T; Rai T; Hoshino J; Ubara Y; Uchida S; Sohara E
    Clin Genet; 2018 Jul; 94(1):125-131. PubMed ID: 29520754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight loss in a patient with polycystic kidney disease: when liver cysts are no longer innocent bystanders.
    Cecere N; Hakem S; Demoulin N; Hubert C; Jabbour N; Goffette P; Pirson Y; Morelle J
    Acta Clin Belg; 2015 Oct; 70(5):369-71. PubMed ID: 25866379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in autosomal-dominant polycystic kidney disease.
    Rangan GK; Tchan MC; Tong A; Wong AT; Nankivell BJ
    Intern Med J; 2016 Aug; 46(8):883-92. PubMed ID: 27553994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal hypertension due to extensive hepatic cysts in autosomal dominant polycystic kidney disease.
    Misra A; Loyalka P; Alva F
    South Med J; 1999 Jun; 92(6):626-7. PubMed ID: 10372860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous transcatheter hepatic artery embolization for liver cysts in autosomal dominant polycystic kidney disease.
    Takei R; Ubara Y; Hoshino J; Higa Y; Suwabe T; Sogawa Y; Nomura K; Nakanishi S; Sawa N; Katori H; Takemoto F; Hara S; Takaichi K
    Am J Kidney Dis; 2007 Jun; 49(6):744-52. PubMed ID: 17533017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital hepatic fibrosis in a child with autosomal dominant polycystic kidney disease.
    Kanaheswari Y; Hamzaini AH; Wong SW
    Med J Malaysia; 2008 Aug; 63(3):251-3. PubMed ID: 19248702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal dominant polycystic kidney disease.
    Cornec-Le Gall E; Alam A; Perrone RD
    Lancet; 2019 Mar; 393(10174):919-935. PubMed ID: 30819518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spanish guidelines for the management of autosomal dominant polycystic kidney disease.
    Ars E; Bernis C; Fraga G; Martínez V; Martins J; Ortiz A; Rodríguez-Pérez JC; Sans L; Torra R;
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv95-105. PubMed ID: 25165191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in autosomal dominant polycystic kidney disease-2014 and beyond.
    Braun WE
    Cleve Clin J Med; 2014 Sep; 81(9):545-56. PubMed ID: 25183846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.